Trial NCT00473486

View at ClinicalTrials.gov 
Org. Study IDs: 2006-005970-26
Secondary IDs: KKS / INNERE_A / NSCLC2006

Last trial update was posted on 2010-01-27

MeSH Interventions

Carboplatin Pemetrexed Sorafenib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

Sorafenib administered in the combination with pemetrexed-carboplatin appears to enhance thrombocytopenia compared to historical data.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID